Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™ Review uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Medical Oncology
  • Practice Patterns, Physicians'

abstract

  • Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment. © Journal of the National Comprehensive Cancer Network.

publication date

  • July 2006

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 16813724

Additional Document Info

start page

  • 548

end page

  • 82

volume

  • 4

number

  • 6